Internal Server Error

About Green Park & Golf Ventures

Green Park & Golf Ventures is a venture capital firm founded in 2011. It is primarily based out of Dallas, United States. As of Jun 2025, Green Park & Golf Ventures has invested in 81 companies. It primarily invests in Seed round in United States based startups. Its investments are spread across a wide range of sectors from Life Sciences to Enterprise Applications and HealthTech. Most recently it participated in the $***** Series A round of Vellum Health Overall, Green Park & Golf Ventures portfolio has seen 5 IPOs and 14 acquisitions including key companies like Savara Pharma, Validic and Lantern Pharma. A lot of funds co-invest with Green Park & Golf Ventures, with names like Capital Factory sharing a substantial percentage of its portfolio. Green Park & Golf Ventures has team of 5 people including 4 partners.
Key Metrics
Portfolio Locations
Rounds of Entry
Seed, Series A & 3 more
Portfolio IPOs
Portfolio Acquisitions
Portfolio Soonicorns

Green Park & Golf Ventures' List of Top Investments

Green Park & Golf Ventures has a portfolio of 81 companies. Their most notable investments are in MicroTransponder and Nasseo.Their portfolio spans across United States, Germany and United Kingdom. They have invested in Life Sciences, Enterprise Applications, HealthTech and 21 other sectors, across stages such as Seed, Series A  and 3 more. Here is the list of top investments by Green Park & Golf Ventures:
Provider of a suite primary care platform for providers. The platform allows patients to connect with healthcare experts through video calls/text messaging. Users can seek medical guidance and receive personalized treatment through online consultations with doctors. Also, it provides home-based diagnostic/lab test solutions for patients. It allows customers to know the specific genes responsible for causing disease. Also, it provides services to healthcare providers, organizations, and payers.

Key facts about Recuro Health

Developer of therapeutics for rare respiratory diseases. The company’s lead product is molgramostim nebulizer solution, which is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) for autoimmune pulmonary alveolar proteinosis (aPAP).

Key facts about Savara Pharma

  • Founded Year: 2008
  • Location: Austin (United States)
  • Annual Revenue: $1M - $10M as on Dec 31, 2011
  • Stage: Public
  • Total Funding till date: $67.8M
  • Employee Count: 124 as on Jul 31, 2026
  • Investors: Bain Capital Life Sciences, Logos and 20 Others
  • Latest Funding Round: Post IPO, Dec 20, 2019, $*****
  • Highlight: Public
Provider of a single-cell multi-omics platform for genotypic and phenotypic analysis. The company's proprietary Tapestri platform enables the simultaneous detection of analytes, including SNVs, CNVs, and proteins for the precise treatment of cancer. Also, it offers DNA & protein panels, and Pharma Assay Development (PAD) Services.

Key facts about Mission Bio

Provider of a single platform that aggregates data from multiple health device connections. It is a cloud-based technology platform that connects patient-recorded data from digital health applications, devices, and wearables to key healthcare companies like hospital systems, providers, pharmaceutical companies, payers, health information technology platforms, health clubs, and wellness companies.

Key facts about Validic

5. Alto

App-based for booking ride hailing services. Users can book rides through the platform by providing location, destination, user details, payment details, preferred dates, and more. The app is available for both Android and iOS devices.

Key facts about Alto

Green Park & Golf Ventures' Investments by Stage

Green Park & Golf Ventures has made 15 investments in Seed stage with an average round size of $1.46M, 11 investments in Series A stage with an average round size of $4.61M, 9 investments in Series B stage with an average round size of $15.9M, 2 investments in Series C stage with an average round size of $3.39M and 1 investment in Conventional Debt stage.
Here are Green Park & Golf Ventures' investments by stage:
Stage of entry
No. of Investments
Seed
15
Series A
11
Series B
9
Series C
2
Conventional Debt
1
Breakdown of Green Park & Golf Ventures' investments by stage of entrySeed (15)Series A (11)
Note: We have considered here, only first round of investments

Green Park & Golf Ventures' Investments by Sector

Green Park & Golf Ventures has a diverse portfolio, with companies operating in the Life Sciences, Enterprise Applications, HealthTech, High Tech and Vertical SaaS. Notably, it has invested in 73 Tech companies, 68 Enterprise (B2B) companies, 39 Software companies and at least 16 companies focusing on Tech hardware.
Here are Green Park & Golf Ventures' investments by sector:
Sector
No. of Investments
Life Sciences
19
Enterprise Applications
15
HealthTech
11
High Tech
6
Vertical SaaS
6
Others
28
Breakdown of Green Park & Golf Ventures' investments by sectorsLife Sciences (19)Enterprise Applic... (15)
Note: We have considered here, only first round of investments

Green Park & Golf Ventures' Investments by Geography

Green Park & Golf Ventures has made most investments in United States (36), followed by Germany where it has made 1 investment.
Here are Green Park & Golf Ventures' investments by geography:
Country
No. of Investments
United States
36
Germany
1
United Kingdom
1
Breakdown of Green Park & Golf Ventures' investments by countriesUnited States (36)Germany (1)
Note: We have considered here, only first round of investments

Green Park & Golf Ventures' recent investments

Green Park & Golf Ventures has not made any investment in 2026 so far.
Here are the most recent investments by Green Park & Golf Ventures:
Date
Company
Location
Round Details
Round Amount
Co-Investors
Jun 26, 2025
United States
Series A
2892
Apr 22, 2025
United States
Seed
9742
  [+2]
Mar 05, 2025
United States
Series F
1665
  [+6]
Feb 03, 2025
United States
Series A
8599
  [+4]
Feb 27, 2024
United States
Seed
5547

IPOs and Publicly Listed companies in Green Park & Golf Ventures' Portfolio

5 of Green Park & Golf Ventures' portfolio companies have become public. Lantern Pharma got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ), in Jun 2020 at marketcap of $93.3M and Atreca got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ) at marketcap of $455M.
Here are Green Park & Golf Ventures' portfolio companies that went public:
Company
IPO Date
First Invested on
First Round of Investment
Round Size
Jun 11, 2020
Feb 26, 2015
Seed
2278
Jun 20, 2019
-
-
6214
Jul 27, 2018
-
-
1004
Apr 27, 2017
-
-
7641
-
-
-
9393

Acquired companies in Green Park & Golf Ventures' Portfolio

14 companies from Green Park & Golf Ventures' portfolio have been acquired. The most recent acquisition was Validic in Jun 2026 by ChartSpan for $*****.
Here are Green Park & Golf Ventures' portfolio companies that got acquired most recently:
Company
Acquisition Date
First Invested on
First Round of Investment
Round Size
Jun 22, 2026
Nov 14, 2022
Series B
2560
Jan 16, 2026
-
-
8856
Aug 22, 2023
Nov 30, 2018
Series A
2258
Jul 29, 2022
Mar 24, 2016
Series B
9063
Dec 20, 2021
Jul 2013
Seed
5573

Team profile of Green Park & Golf Ventures

Green Park & Golf Ventures has a team of 5 members including 4 Partners and 1 Principal located in United States. Green Park & Golf Ventures' team does not sit on the board of any company as of now.
Here is a list of all team members in Green Park & Golf Ventures:
Name
Designation
Location
Board Memberships
Contact Details
Partner
Dallas
-
Partner
Dallas
-
Partner
Austin
-
-
Partner
Dallas
-
Principal
Houston
-

Co-investors of Green Park & Golf Ventures

Over the past 14 years, 157 investors have co-invested in Green Park & Golf Ventures's portfolio companies. This includes funds and angels.

  • Invested before Green Park & Golf VenturesHHS, Health Wildcatters and 46 others have invested in rounds before Green Park & Golf Ventures. There are 8 companies where HHS has invested before Green Park & Golf Ventures and 4 companies where Health Wildcatters has invested before Green Park & Golf Ventures.
  • Top Co-investors of Green Park & Golf Ventures63 investors entered a company along with Green Park & Golf Ventures. These include investors like Capital Factory (3 companies).
  • Invested after Green Park & Golf VenturesA total of 46 investors have invested in Green Park & Golf Ventures's portfolio after their investments. Top Investors include Perot Jain (2 companies), NIH (2 companies) and Flippen Group (1 company).

Recent News related to Green Park & Golf Ventures

View all news related to Green Park & Golf Ventures

FAQs about Green Park & Golf Ventures

Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford